Nifty
Sensex
:
:
25044.35
82055.11
72.45 (0.29%)
158.32 (0.19%)

Pharmaceuticals & Drugs

Rating :
65/99

BSE: 543427 | NSE: MEDPLUS

887.35
24-Jun-2025
  • Open
  • High
  • Low
  • Previous Close
  •  875
  •  895.3
  •  875
  •  870.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  75690
  •  67133388.15
  •  1045.3
  •  616

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 10,631.42
  • 69.25
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 10,264.20
  • N/A
  • 5.98

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 40.34%
  • 3.11%
  • 13.10%
  • FII
  • DII
  • Others
  • 15.61%
  • 23.85%
  • 3.99%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 14.40
  • 14.17

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 22.67
  • 5.15

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 105.42
  • -11.92

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 136.03

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 5.72

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 24.45

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
5.48
12.57
17.25
23.19
P/E Ratio
158.88
69.26
50.47
37.54
Revenue
5625
6136
6916
7944
EBITDA
354
487
605
732
Net Income
65
150
210
286
ROA
2.3
4.7
6
7.7
P/B Ratio
8.76
5.98
5.40
4.73
ROE
4.27
9.06
11.33
13.74
FCFF
73
495
401
430
FCFF Yield
0.59
4.02
3.26
3.49
Net Debt
868
753
-433
-552
BVPS
99.35
145.61
161.32
184.02

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
1,509.61
1,490.50
1.28%
1,561.45
1,441.47
8.32%
1,576.17
1,408.59
11.90%
1,488.83
1,284.30
15.93%
Expenses
1,373.24
1,384.63
-0.82%
1,428.92
1,349.69
5.87%
1,451.73
1,323.50
9.69%
1,395.06
1,212.95
15.01%
EBITDA
136.37
105.87
28.81%
132.52
91.78
44.39%
124.44
85.09
46.25%
93.76
71.34
31.43%
EBIDTM
9.03%
7.10%
8.49%
6.37%
7.89%
6.04%
6.30%
5.56%
Other Income
15.79
10.46
50.96%
12.52
9.79
27.89%
11.60
10.37
11.86%
8.71
9.39
-7.24%
Interest
26.84
25.13
6.80%
25.97
24.50
6.00%
25.12
23.54
6.71%
24.66
23.27
5.97%
Depreciation
64.21
59.21
8.44%
62.47
57.11
9.39%
63.14
55.47
13.83%
60.03
52.41
14.54%
PBT
61.12
31.99
91.06%
56.60
19.96
183.57%
47.78
16.44
190.63%
17.79
5.05
252.28%
Tax
9.80
-1.58
-
10.73
6.26
71.41%
9.08
1.90
377.89%
3.44
1.29
166.67%
PAT
51.32
33.56
52.92%
45.87
13.71
234.57%
38.70
14.54
166.16%
14.34
3.76
281.38%
PATM
3.40%
2.25%
2.94%
0.95%
2.46%
1.03%
0.96%
0.29%
EPS
4.29
2.79
53.76%
3.83
1.15
233.04%
3.24
1.22
165.57%
1.20
0.32
275.00%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Net Sales
6,136.06
5,624.85
4,557.58
3,779.28
3,069.27
2,870.60
Net Sales Growth
9.09%
23.42%
20.59%
23.13%
6.92%
 
Cost Of Goods Sold
4,640.67
4,391.63
3,557.69
2,982.37
2,425.24
2,336.54
Gross Profit
1,495.39
1,233.23
999.89
796.90
644.03
534.07
GP Margin
24.37%
21.92%
21.94%
21.09%
20.98%
18.60%
Total Expenditure
5,648.95
5,253.56
4,276.21
3,490.40
2,840.05
2,736.93
Power & Fuel Cost
-
45.50
31.71
17.78
13.29
13.70
% Of Sales
-
0.81%
0.70%
0.47%
0.43%
0.48%
Employee Cost
-
625.52
545.13
393.92
338.65
272.40
% Of Sales
-
11.12%
11.96%
10.42%
11.03%
9.49%
Manufacturing Exp.
-
9.11
6.19
4.57
6.18
8.28
% Of Sales
-
0.16%
0.14%
0.12%
0.20%
0.29%
General & Admin Exp.
-
76.56
62.06
39.66
24.88
21.00
% Of Sales
-
1.36%
1.36%
1.05%
0.81%
0.73%
Selling & Distn. Exp.
-
98.28
67.76
47.35
29.27
47.58
% Of Sales
-
1.75%
1.49%
1.25%
0.95%
1.66%
Miscellaneous Exp.
-
6.96
5.67
4.75
2.54
37.43
% Of Sales
-
0.12%
0.12%
0.13%
0.08%
1.30%
EBITDA
487.09
371.29
281.37
288.88
229.22
133.67
EBITDA Margin
7.94%
6.60%
6.17%
7.64%
7.47%
4.66%
Other Income
48.62
40.01
46.08
31.36
21.55
17.28
Interest
102.59
113.65
98.72
82.94
67.40
46.80
Depreciation
249.85
224.21
181.56
119.36
88.27
74.81
PBT
183.29
73.44
47.16
117.94
95.10
29.36
Tax
33.05
7.87
-2.94
23.23
31.99
27.57
Tax Rate
18.03%
10.72%
-6.23%
19.70%
33.64%
93.90%
PAT
150.23
65.48
49.76
95.81
63.86
1.79
PAT before Minority Interest
150.33
65.58
50.10
94.72
63.11
1.79
Minority Interest
0.10
-0.10
-0.34
1.09
0.75
0.00
PAT Margin
2.45%
1.16%
1.09%
2.54%
2.08%
0.06%
PAT Growth
129.11%
31.59%
-48.06%
50.03%
3,467.60%
 
EPS
12.55
5.47
4.16
8.00
5.34
0.15

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Shareholder's Funds
1,577.93
1,491.18
1,417.77
730.55
527.80
Share Capital
23.91
23.86
23.86
0.45
0.19
Total Reserves
1,523.66
1,436.88
1,382.52
681.45
291.47
Non-Current Liabilities
839.74
797.40
647.39
381.01
298.35
Secured Loans
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
55.71
61.33
94.94
18.35
17.74
Current Liabilities
525.93
476.58
559.01
444.84
481.09
Trade Payables
253.03
260.14
246.23
148.09
234.15
Other Current Liabilities
241.81
189.35
148.29
111.39
122.35
Short Term Borrowings
0.00
0.00
142.68
135.24
105.05
Short Term Provisions
31.09
27.09
21.80
50.12
19.54
Total Liabilities
2,943.03
2,764.48
2,623.65
1,556.95
1,308.54
Net Block
1,241.83
1,137.96
798.73
517.30
419.46
Gross Block
1,861.94
1,615.62
1,114.11
739.16
689.67
Accumulated Depreciation
620.11
477.66
315.38
221.86
270.21
Non Current Assets
1,375.48
1,283.77
991.95
603.97
492.76
Capital Work in Progress
11.08
25.47
20.45
5.54
4.94
Non Current Investment
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
116.72
120.19
172.75
81.08
68.33
Other Non Current Assets
5.85
0.15
0.02
0.05
0.04
Current Assets
1,567.55
1,480.72
1,631.71
952.98
815.78
Current Investments
0.00
0.03
0.03
0.03
0.25
Inventories
1,340.23
1,144.09
914.98
749.96
643.55
Sundry Debtors
17.50
8.65
6.04
5.37
6.40
Cash & Bank
141.68
283.83
34.41
118.59
140.69
Other Current Assets
68.13
9.91
31.74
7.69
24.87
Short Term Loans & Adv.
53.84
34.20
644.51
71.34
18.16
Net Current Assets
1,041.62
1,004.14
1,072.70
508.14
334.69
Total Assets
2,943.03
2,764.49
2,623.66
1,556.95
1,308.54

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Cash From Operating Activity
143.74
90.41
169.89
2.89
-6.59
PBT
73.44
47.16
117.94
95.10
29.36
Adjustment
330.62
272.76
187.88
182.28
155.41
Changes in Working Capital
-231.10
-215.58
-102.37
-245.77
-176.50
Cash after chg. in Working capital
172.96
104.34
203.45
31.61
8.27
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-29.22
-13.94
-33.56
-28.71
-14.86
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-82.80
429.44
-703.13
-34.55
-27.55
Net Fixed Assets
-17.99
-111.19
-80.06
-17.76
Net Investments
-12.56
-498.71
-9.95
-27.41
Others
-52.25
1,039.34
-613.12
10.62
Cash from Financing Activity
-198.10
-170.25
440.43
-5.63
89.83
Net Cash Inflow / Outflow
-137.17
349.60
-92.81
-37.28
55.69
Opening Cash & Equivalents
228.38
-121.23
-28.42
8.87
-46.82
Closing Cash & Equivalent
91.21
228.38
-121.23
-28.42
8.87

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Book Value (Rs.)
129.47
122.44
117.89
3044.19
15034.43
ROA
2.30%
1.86%
4.51%
4.40%
0.18%
ROE
4.36%
3.50%
9.07%
12.96%
0.59%
ROCE
12.19%
9.56%
16.56%
21.69%
14.34%
Fixed Asset Turnover
3.28
3.39
4.13
4.38
6.75
Receivable days
0.84
0.58
0.54
0.69
0.96
Inventory Days
79.52
81.27
79.28
81.18
65.97
Payable days
21.33
25.98
24.13
28.76
24.12
Cash Conversion Cycle
59.03
55.87
55.69
53.10
42.81
Total Debt/Equity
0.00
0.00
0.10
0.20
0.36
Interest Cover
1.65
1.48
2.42
2.41
1.63

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.